DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1ACAMPROSATE CALCIUM
02 1DIVALPROEX SODIUM
03 1ESOMEPRAZOLE MAGNESIUM
04 1MYCOPHENOLIC SODIUM
05 1NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
06 3PANTOPRAZOLE SODIUM
01 177296
02 177619
03 190797
04 191231
05 1200143
06 1204206
07 1209202
08 1214376
01 8No
ESOMEPRAZOLE MAGNESIUM; NAPROXEN
Drug : NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 204206
Country : US
Patented : No
Drug : PANTOPRAZOLE SODIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 90797
Country : US
Patented : No
Drug : MYCOPHENOLIC SODIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 214376
Country : US
Patented : No
Drug : ACAMPROSATE CALCIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 200143
Country : US
Patented : No
Drug : DIVALPROEX SODIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 77296
Country : US
Patented : No
Drug : ESOMEPRAZOLE MAGNESIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 209202
Country : US
Patented : No
Drug : PANTOPRAZOLE SODIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 91231
Country : US
Patented : No
Drug : PANTOPRAZOLE SODIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 77619
Country : US
Patented : No
LOOKING FOR A SUPPLIER?